MALAT1 and hematologic disorder: In concert with MALAT1, also NEAT1 is emerging as a novel biomarker and crucial regulator in the pathogenesis of several human tumors although with distinct roles in solid tumors versus hematological malignancies (Ghafouri-Fard and Taheri, 2019).